{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [
    [
      "Antidepressants",
      "BDNF",
      "Depression",
      "GPR39",
      "NMDA",
      "Zinc"
    ]
  ],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "25490458",
  "DateCompleted": {
    "Year": "2015",
    "Month": "08",
    "Day": "03"
  },
  "DateRevised": {
    "Year": "2021",
    "Month": "05",
    "Day": "26"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2014",
        "Month": "11",
        "Day": "26"
      }
    ],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "10.1016/j.jad.2014.11.033",
      "S0165-0327(14)00743-5"
    ],
    "Journal": {
      "ISSN": "1573-2517",
      "JournalIssue": {
        "Volume": "174",
        "PubDate": {
          "Year": "2015",
          "Month": "Mar",
          "Day": "15"
        }
      },
      "Title": "Journal of affective disorders",
      "ISOAbbreviation": "J Affect Disord"
    },
    "ArticleTitle": "GPR39 Zn(2+)-sensing receptor: a new target in antidepressant development?",
    "Pagination": {
      "StartPage": "89",
      "EndPage": "100",
      "MedlinePgn": "89-100"
    },
    "Abstract": {
      "AbstractText": [
        "Zinc is a trace element released from glutamatergic terminals, and modulates the pre- and postsynaptic areas, giving a diverse biological response. Zinc is a natural ligand that inhibits the N-methyl-d-aspartate (NMDA) receptor and regulates the excessive release of glutamate. Moreover, zinc exhibits an antidepressant-like profile, as demonstrated in both preclinical and clinical studies. Recent reports indicate that the GPR39 Zn(2+)-sensing receptor is an important target for zinc \"transmission\" (its activation modulates/induces diverse biochemical pathways involved in neuroprotection). Preclinical studies provide evidence that zinc deficiency leads to depressive-like behavior related to down-regulation of the GPR39 Zn(2+)-sensing receptor. Zinc binds to the GPR39 and triggers signals, leading to CRE-dependent gene transcription, resulting in increases in proteins such as brain-derived neurotrophic factor (BDNF), that plays a pivotal role in antidepressant action. Chronic administration of many antidepressants induces GPR39 up-regulation, which suggests that the Zn(2+)-sensing receptor may be considered as a new target for drug development in the field of depression."
      ],
      "CopyrightInformation": "Copyright \u00a9 2014 Elsevier B.V. All rights reserved."
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Biochemical Toxicology, Jagiellonian University Medical College, Medyczna 9, PL 30-688 Krak\u00f3w, Poland. Electronic address: katarzyna.mlyniec@uj.edu.pl."
          }
        ],
        "LastName": "M\u0142yniec",
        "ForeName": "Katarzyna",
        "Initials": "K"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Pharmacology and Toxicology, Institute of Pharmacy and Center for Molecular Biosciences Innsbruck (CMBI), University of Innsbruck, Innrain 80-82/III, A-6020 Innsbruck, Austria."
          }
        ],
        "LastName": "Singewald",
        "ForeName": "Nicolas",
        "Initials": "N"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Neuroscience and Pharmacology University of Copenhagen, Blegdamsvej 3, DK-2200 Copenhagen, Denmark."
          }
        ],
        "LastName": "Holst",
        "ForeName": "Birgitte",
        "Initials": "B"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Pharmacobiology, Jagiellonian University Medical College, Medyczna 9, PL 30-688 Krak\u00f3w, Poland; Department of Neurobiology, Institute of Pharmacology, Polish Academy of Sciences, Sm\u0119tna 12, PL 31-343 Krak\u00f3w, Poland."
          }
        ],
        "LastName": "Nowak",
        "ForeName": "Gabriel",
        "Initials": "G"
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Research Support, Non-U.S. Gov't",
      "Review"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "Netherlands",
    "MedlineTA": "J Affect Disord",
    "NlmUniqueID": "7906073",
    "ISSNLinking": "0165-0327"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Antidepressive Agents"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Brain-Derived Neurotrophic Factor"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "GPR39 protein, human"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Neuroprotective Agents"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Receptors, G-Protein-Coupled"
    },
    {
      "RegistryNumber": "3KX376GY7L",
      "NameOfSubstance": "Glutamic Acid"
    },
    {
      "RegistryNumber": "7171WSG8A2",
      "NameOfSubstance": "BDNF protein, human"
    },
    {
      "RegistryNumber": "J41CSQ7QDS",
      "NameOfSubstance": "Zinc"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "Animals"
    },
    {
      "QualifierName": [
        "pharmacology",
        "therapeutic use"
      ],
      "DescriptorName": "Antidepressive Agents"
    },
    {
      "QualifierName": [
        "metabolism"
      ],
      "DescriptorName": "Brain"
    },
    {
      "QualifierName": [
        "metabolism"
      ],
      "DescriptorName": "Brain-Derived Neurotrophic Factor"
    },
    {
      "QualifierName": [
        "drug therapy",
        "metabolism",
        "psychology"
      ],
      "DescriptorName": "Depression"
    },
    {
      "QualifierName": [
        "drug therapy",
        "metabolism",
        "psychology"
      ],
      "DescriptorName": "Depressive Disorder"
    },
    {
      "QualifierName": [
        "metabolism"
      ],
      "DescriptorName": "Glutamic Acid"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Learning"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Memory"
    },
    {
      "QualifierName": [
        "methods"
      ],
      "DescriptorName": "Molecular Targeted Therapy"
    },
    {
      "QualifierName": [
        "metabolism"
      ],
      "DescriptorName": "Mood Disorders"
    },
    {
      "QualifierName": [
        "pharmacology"
      ],
      "DescriptorName": "Neuroprotective Agents"
    },
    {
      "QualifierName": [
        "drug effects",
        "metabolism"
      ],
      "DescriptorName": "Receptors, G-Protein-Coupled"
    },
    {
      "QualifierName": [
        "drug effects"
      ],
      "DescriptorName": "Signal Transduction"
    },
    {
      "QualifierName": [
        "drug effects"
      ],
      "DescriptorName": "Up-Regulation"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Weight Gain"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Weight Loss"
    },
    {
      "QualifierName": [
        "deficiency",
        "metabolism"
      ],
      "DescriptorName": "Zinc"
    }
  ]
}